Dr. Jones co-founded Celltex Therapeutics with David Eller in 2011 for regenerative medicine through adult stem cells. The article features a young patient who underwent the stem cell therapy successfully relieve pain. The proprietary technology is designed to:
• Isolate adult autologous mesenchymal stem cells
• Multiply the cells
• Store the cells for later use in regenerative therapy
The therapy can be used for multiple vascular, autoimmune and degenerative diseases. Dr. Jones has been working to bring the technology to the United States for the past few years, and received the therapy in Asia for a spinal procedure.
More articles on spine surgery:
What dural closure methods are best for spine surgery? 5 things to know
Can a new peptide promote lumbar spinal fusion? 5 key notes
Dr. Patrick Hitchon becomes associate editor of Clinical Neurology and Neurosurgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
